Introduction {#s0001}
============

High-voltage-activated (HVA) calcium channels (Ca~V~1.1--1.4, Ca~V~2.1--2.3) couple electrical excitation to physiological responses in excitable cells.[@cit0001] These channels are hetero-oligomeric protein complexes comprising a pore-forming α~1~-subunit assembled with auxiliary proteins that include β/α~2~δ/γ subunits and calmodulin.[@cit0002] There are 7 genes coding for HVA calcium channel α~1~-subunits, each with multiple splice variants. The transmembrane α~1~-subunit defines the channel subtype and contains the voltage sensor, the selectivity filter, and the water-filled pore that provides a passageway for Ca^2+^ ions to traverse the hydrophobic plasma membrane. The auxiliary subunits profoundly regulate the trafficking and gating properties of α~1~-subunits and are essential for the physiological function of Ca~V~1/Ca~V~2 channels. In particular, Ca~V~β (β~1~-β~4~) is crucial for forming functional Ca~V~1/Ca~V~2 channels as it is obligatory for α~1~ trafficking to the cell surface, increases the open probability (*P*~*O*~) of surface channels, and imposes isoform-dependent inactivation gating signatures.[@cit0004] Modulation of specific Ca~V~1/Ca~V~2 channels by signaling proteins, Ca^2+^ ions, or small molecules is a powerful method to regulate diverse aspects of physiology including cardiac contractility, synaptic plasticity, insulin release, and gene expression.[@cit0002] Molecules that block Ca~V~1/Ca~V~2 channels with high specificity and potency are sought after as therapeutics for various cardiovascular and neurological disorders including cardiac arrhythmias, pain, and neurodegenerative diseases.[@cit0010]

Rad, Rem, Rem2 and Gem/Kir (RGK) proteins are Ras-like monomeric G-proteins that potently and non-selectively inhibit all Ca~V~1/Ca~V~2 channels.[@cit0013] Distinct RGK proteins are expressed in muscle, neurons, pancreas, and immune cells, and knockout mice studies suggest their inhibition of Ca~V~ channels is physiologically relevant in different systems.[@cit0017] The potential of using RGK proteins as precisely targeted genetically-encoded Ca~V~ channel blockers for therapeutic applications has been explored in proof-of-concept experiments in heart *in vivo* and *in vitro*.[@cit0023] A major limitation to the practical use of RGKs as Ca~V~ channel blockers is that they non-selectively inhibit Ca~V~1/Ca~V~2 channels. Development of selective RGK-derived Ca~V~1/Ca~V~2 channel inhibitors could accelerate their applied use as genetically-encoded Ca~V~ channel blockers.

All four RGK proteins interact directly with Ca~V~β.[@cit0013] Recently, we examined the role of Rem/Ca~V~β interaction in Rem inhibition of recombinant Ca~V~1.2 channels using a mutant β~2a~ (β~2aTM~) which contains point mutations (D243A, D319A and D321A) that selectively abolish binding to RGK proteins,[@cit0025] but retains the capacity to modulate Ca~V~1/Ca~V~2 channel trafficking and gating.[@cit0026] We discovered that Rem utilizes 2 independent pathways to inhibit Ca~V~1.2 channels---a β-binding-dependent (BBD) mode and a direct α~1C~-binding-dependent (ABD) mechanism, respectively. The BBD pathway likely explains the indiscriminate nature of RGK inhibition since all Ca~V~1/Ca~V~2 channels require assembly with β for their functional maturation.[@cit0004] Understanding the molecular bases for the ABD Rem inhibition of Ca~V~1.2 is of special interest because this mechanism could potentially be exploited to develop Ca~V~1/Ca~V~2 isoform-selective channel blockers. The ABD mechanism of Ca~V~1.2 inhibition requires Rem binding to α~1C~ N-terminus (α~1C~NT).[@cit0026] However, the determinants on Rem itself necessary for binding α~1C~NT and initiating ABD Ca~V~1.2 inhibition are unknown. Here, we report that the Rem distal C-terminus (Rem~DCT~) and guanine nucleotide binding domain (G-domain) are both required for ABD Ca~V~1.2 inhibition. Rem~DCT~ binds α~1C~NT anchoring the G-domain, which presumably engages with an as-yet-unidentified site either within the channel complex or elsewhere, to initiate Ca~V~1.2 inhibition. Remarkably, these same Rem determinants---Rem~DCT~ and G-domain---are also utilized, but with different interaction partners (plasma membrane and Ca~V~β, respectively), for BBD Ca~V~1.2 inhibition.[@cit0026]

Results {#s0002}
=======

Rem and Gem differ in their capacity to use an α~1C~-binding-dependent mechanism to inhibit Ca~V~1.2 channels {#s0002-0001}
-------------------------------------------------------------------------------------------------------------

It is now well-established that RGK proteins strongly inhibit currents through Ca~V~1/Ca~V~2 channels.[@cit0013] Here, we recapitulate this effect by examining the impact of Rem and Gem on Ca~V~1.2 channels reconstituted by transient transfection of HEK293 cells with α~1C~ + β~2a~ subunits. As expected, control cells express large whole-cell L-type currents (*I*~Ca,L~) which are deeply inhibited equally by either co-expressed Rem or Gem ([Fig. 1A, B](#f0001){ref-type="fig"}). To isolate the ABD component underlying RGK inhibition of *I*~Ca,L~, we reconstituted Ca~V~1.2 with a β~2a~ triple mutant (β~2aTM~) that does not bind RGKs but retains modulatory actions on the channel complex.[@cit0025] Channels reconstituted with α~1C~ + β~2aTM~ display robust currents which are differentially affected by Rem and Gem, respectively. Whereas Rem significantly inhibits α~1C~ + β~2aTM~ channels, Gem has no impact on *I*~Ca,L~ through these mutant Ca~V~1.2 channels ([Fig. 1C,D](#f0002){ref-type="fig"}). These results confirm our recent finding that Gem uses a solely BBD mechanism to inhibit Ca~V~1.2 channels, whereas Rem uses both BBD and ABD pathways to achieve *I*~Ca,L~ block.[@cit0026] Figure 1.Rem and Gem differ in their capacity to use a α~1C~-binding-dependent mechanism to inhibit Ca~V~1.2 channels. (A) Exemplar Ba[@cit0002]^+^ currents from HEK293 cells expressing wild-type Ca~V~1.2 (α~1C~ + β~2a~) (*left*) in the presence of either Rem (*middle*) or Gem (*right*). (B) Population current density (*J*~peak~) vs. voltage relationships for wild-type Ca~V~1.2 channels (▪, *n* = 6) co-expressed with either Rem (![](kchl-10-05-1180489-i001.jpg),*n* = 3) or Gem (![](kchl-10-05-1180489-i003.jpg),*n* = 4). (C) Exemplar Ba[@cit0002]^+^ currents from HEK293 cells expressing mutant Ca~V~1.2 (α~1C~ + β~2aTM~) (*left*) in the presence of either Rem (*middle*) or Gem (*right*). (D) *J*~peak~─*voltage* relationships for mutant Ca~V~1.2 channels (▪, *n* = 9) co-expressed with Rem (![](kchl-10-05-1180489-i001.jpg),*n* = 7) or Gem (![](kchl-10-05-1180489-i003.jpg),*n* = 8). Data are means ± SEM. Figure 2.Cardiac myocytes possess a β-binding-independent mechanism to inhibit endogenous Ca~V~1.2 channels. (A) *Top*, Gray scale image of rat ventricular myocyte. Scale bar, 10 μm. *Bottom*, representative whole-cell Ca~V~1.2 channel currents from a cultured rat ventricular myocyte expressing CFP-α~1C~NT (▪, *n* = 8). (B) Population *J*~peak~─*V* relationship for control cardiomyocytes. (C-H) Data for cardiomyocytes expressing Rem-IRES-mCherry (![](kchl-10-05-1180489-i001.jpg),*n* = 8), CFP-α~1C~NT + Rem-IRES-mCherry (О, *n* = 10) and CFP-α~1C~II-III loop + Rem-IRES-mCherry (▿, *n* = 8), respectively; same format as A and B. Data for control (cyan line) and Rem-IRES-mCherry (red line) are reproduced for comparison. \* *P* \< 0.05 compared to either Rem-IRES-mCherry or control, one-way ANOVA.

α~1C~-binding-dependent Rem inhibition of *I*~Ca,L~ occurs in cardiac myocytes {#s0002-0002}
------------------------------------------------------------------------------

The molecular determinants and mechanisms that distinct RGK proteins use to inhibit Ca~V~ channels can differ substantively in different cell types.[@cit0030] Whether Rem inhibits endogenous Ca~V~1.2 channels in their native context using the ABD mechanism is unknown. This information is crucial to gauge the potential physiological significance of this mode of channel inhibition and whether it can be exploited to design generally useful Ca~V~1/Ca~V~2 isoform-selective inhibitors. We previously showed that over-expressing an α~1C~NT peptide eliminates ABD Ca~V~1.2 inhibition by competitively interfering with Rem binding to the full-length α~1C~ N-terminus.[@cit0026] We exploited this approach to determine whether Rem inhibits endogenous Ca~V~1.2 channels in cardiac myocytes using the ABD mechanism.

Whole-cell patch clamp of cultured adult rat ventricular myocytes yielded large Ba^2+^ currents ([Fig. 2, A and B](#f0002){ref-type="fig"}; *I*~peak~ = −15.5 ± 1.6 pA/pF, *n* = 8). Adenoviral-mediated over-expression of Rem-IRES-mCherry dramatically inhibited whole-cell current ([Fig. 2, C and D](#f0002){ref-type="fig"}; *I*~peak~ = −1.2 ± 0.2 pA/pF, *n* = 8; *P* \< 0.05 compared to control). Co-expressing CFP-α~1C~NT together with Rem-IRES-mCherry resulted in a partial rescue of current ([Fig. 2, E and F](#f0002){ref-type="fig"}; *I*~peak~ = −5.6 ± 1.2 pA/pF, *n* = 8; *P* \< 0.05 compared to Rem-IRES-mCherry alone), consistent with a significant contribution of the ABD mechanism to Rem inhibition of Ca~V~1.2 in cardiac myocytes. This result was not due to the potentially trivial explanation that co-infecting myocytes with 2 adenoviruses led to reduced Rem expression because co-expressing CFP-α~1C~ II-III loop did not appreciably rescue current blocked by Rem-IRES-mCherry ([Fig. 2, G and H](#f0002){ref-type="fig"}; *I*~peak~ = −1.9 ± 0.3 pA/pF, *n* = 8). Patched cells were monitored for CFP and mCherry fluorescence ensuring that both proteins were expressed in the selected cardiomyocytes (Fig. S1).

These results demonstrate that ABD Rem inhibition of Ca~V~1.2 occurs in a physiological context and provided strong motivation to probe the Rem molecular determinants underlying this mode of Ca~V~1.2 inhibition.

Rem distal C-terminus interacts with α~1C~NT {#s0002-0003}
--------------------------------------------

How does Rem interact with α~1C~NT, and are the determinants for this interaction lacking in Gem? Initial expectations for answers to these questions were derived from comparing Rem and Gem primary sequences. Mouse Rem contains 297 amino acids and can be nominally divided into 3 parts based on comparison with the prototypical Ras: N-terminus (residues 1--77), G-domain (residues 78--246), and C-terminus (residues 247--297) ([Fig. 3](#f0003){ref-type="fig"}). Ras is principally composed of a G-domain, a structure comprised of a 6-stranded β-sheet surrounded by 5 α-helices with 5 conserved loops (G1-G5) that form the guanine-nucleotide binding site.[@cit0036] The G-domains of all 4 RGK proteins are highly conserved, bind guanine nucleotides, and adopt a similar structural fold as the Ras G-domain.[@cit0015] The N-terminus extensions of Rem and Gem are variable (\< 30% homology); the C-termini extensions contain a variable proximal region (PCT; residues 247--257 in Rem and 244--256 in Gem, respectively) and a conserved distal region (DCT; 70% homology) ([Fig. 3](#f0003){ref-type="fig"}). Figure 3.Primary sequence alignment of Rem and Gem. Sequence alignment of murine Rem, human Gem and human H-Ras. Identical residues are shaded green; similar residues are shaded in cyan. PCT, proximal C-terminus; DCT, distal C-terminus.

We used a 3-cube fluorescence resonance energy transfer (FRET) assay[@cit0039] to determine which regions of Rem associate with α~1C~NT and how these compared with determinants required for binding Ca~V~β ([Fig. 4](#f0004){ref-type="fig"}) We generated YFP-α~1C~NT and YFP-β~3~, respectively, and used these in 3-cube FRET experiments with CFP-tagged wild-type (wt) Rem and Rem-deletion mutants, respectively. As a negative control for these experiments, we first measured FRET between CFP-FRB and either YFP-α~1C~NT or YFP-β~3~, respectively. FRB is the rapamycin-binding domain from the kinase mTor,[@cit0042] and is not expected to associate with either YFP-α~1C~NT or YFP-β~3~. HEK293 cells co-expressing CFP-FRB and either YFP-α~1C~NT or YFP-β~3~ displayed low FRET efficiencies (FRET~eff~) of 0.018 ± 0.005 and 0.031 ± 0.004, respectively ([Fig. 4, B and C](#f0004){ref-type="fig"}). By contrast, cells expressing CFP-Rem and either YFP-α~1C~NT or YFP-β~3~ displayed significantly elevated FRET~eff~ of 0.147 ± 0.011 (*n* = 37) and 0.150 ± 0.007 (*n* = 42), respectively ([Fig. 4, B and C](#f0004){ref-type="fig"}). A truncated Rem lacking the final 32 amino acids of the C-terminus (CFP-Rem~1--265~) displayed no interaction with YFP-α~1C~NT (FRET~eff~ = 0.037 ± 0.005, *n* = 33) ([Fig. 4B](#f0004){ref-type="fig"}), while the association with YFP-β~3~ was preserved (FRET~eff~ = 0.125 ± 0.008, *n* = 40) ([Fig. 4C](#f0004){ref-type="fig"}). Conversely, CFP-Rem~224--297~ which lacks the Rem N-terminus and most of the G-domain showed robust binding to YFP-α~1C~NT (FRET~eff~ = 0.439 ± 0.035, *n* = 20) but no interaction with YFP-β~3~ (FRET~eff~ = 0.040 ± 0.004, *n* = 35) ([Fig. 4, B and C](#f0004){ref-type="fig"}). Consistent with these results, YFP-Rem, but not YFP-Rem~265~, interacted with full-length CFP-α~1C~ as reported by an elevated FRET efficiency (Fig. S2). Figure 4.FRET detection of Rem determinants underlying interaction with α~1C~ N-terminus and Ca~V~β. (A) Schematic of α~1C~, Ca~V~β, and Rem. Rem interacts independently with Ca~V~β and α~1C~ N-terminus. (B) FRET detection of interactions between YFP-α~1C~NT and distinct CFP-tagged wt or truncated Rem constructs. \**P* \< 0.05 compared with CFP-FRB using one-way ANOVA and Bonferroni test (C) FRET detection of interactions between YFP-Ca~V~β~3~ and distinct CFP-tagged wt or truncated Rem constructs. \**P* \< 0.05 compared with CFP-FRB using one-way ANOVA and Bonferroni test. Data are means ± SEM.

Taken together with previous results, these data support the binary interpretation that separate determinants underlie Rem binding to α~1C~NT and Ca~V~β, respectively: the Rem~DCT~ is responsible for association with α~1C~NT but plays no role in binding Ca~V~β; Rem G-domain mediates interaction with Ca~V~β but does not contribute to α~1C~NT binding.

Rem~DCT~ determinants required for binding α~1C~NT and ABD Ca~V~1.2 inhibition {#s0002-0004}
------------------------------------------------------------------------------

To more precisely localize the residues within Rem~DCT~ responsible for binding α~1C~NT we generated 2 additional Rem deletion mutants (CFP-Rem~1--285~ and CFP-Rem~1--275~) and used FRET to assess their interaction with YFP-α~1C~NT ([Fig. 5](#f0005){ref-type="fig"}). CFP-Rem~1--285~ co-expressed with YFP-α~1C~NT yielded a robust FRET signal (FRET~eff~ = 0.071 ± 0.01, *n* = 32) that was comparable to that obtained with wt CFP-Rem (FRET~eff~ = 0.085 ± 0.009, *n* = 24, *P* = 1 compared to CFP-Rem~1--285~) ([Fig. 5B](#f0005){ref-type="fig"}). By contrast, CFP-Rem~1--275~ displayed a significantly reduced FRET signal when co-expressed with YFP-α~1C~NT (FRET~eff~ = 0.040 ± 0.009, *n* = 13, *P* = 0.028 compared to CFP-Rem, one-way ANOVA), consistent with reduced binding between the 2 proteins ([Fig. 5B](#f0005){ref-type="fig"}). These results were bolstered by complementary co-immunoprecipitation experiments ([Fig. 5C](#f0005){ref-type="fig"}). We co-expressed CFP-tagged wt Rem or the deletion mutants without (lane 1) or with (lanes 2--5) YFP-α~1C~NT in HEK293 cells. Western blots of whole-cell lysates using anti-GFP antibody showed similar expression levels of all the Rem constructs, and confirmed the presence of co-expressed YFP-α~1C~NT ([Fig. 5C, *top*](#f0005){ref-type="fig"}). Immunoprecipitation using anti-Rem antibody led to comparable pull-down of all the Rem constructs. However, the amount of YFP-α~1C~NT that was co-immunoprecipitated differed among the various groups. A comparable amount of YFP-α~1C~NT was pulled down with CFP-Rem and CFP-Rem~1--285~, respectively. By comparison, a substantially lower quantity of YFP-α~1C~NT was co-immunoprecipitated with CFP-Rem~1--275~ and CFP-Rem~1--265~, respectively. Figure 5.Mapping Rem distal C-terminus determinants required for β-binding-dependent and α~1C~-binding-dependent inhibition of Ca~V~1.2 (A) Sequence of Rem C-terminus with truncation sites indicated for Rem~1--265~, Rem~1--275~, and Rem~1--285~. (B) FRET detection of interactions between YFP-α~1C~NT and distinct CFP-tagged wt or truncated Rem constructs. \**P* \< 0.05 compared with CFP-Rem using one-way ANOVA and Bonferroni test. Data are means ± SEM (C) Co-immunoprecipitation detection of interactions between YFP-α~1C~NT and CFP-tagged wt or truncated Rem constructs. Top panel shows Western blot of whole-cell lysates (input). (D) Bar chart showing mean peak current density from wild-type (black) and mutant (white) Ca~V~1.2 channels ± wt or truncated Rem constructs. \#*P* \< 0.05 compared with α~1C~ + β~2a~ using one-way ANOVA and Bonferroni tests. \**P* \< 0.05 compared with α~1C~ + β~2aTM~ using one-way ANOVA and Bonferroni tests. Data are means ± SEM.

We next comparatively evaluated how effectively the distinct Rem C-terminus deletion mutants inhibited Ca~V~1.2 channels using the BBD and ABD mechanisms, respectively. Cells expressing either wt (α~1C~/β~2a~) or mutant (α~1C~/β~2aTM~) Ca~V~1.2 channels were both inhibited by wt Rem but unaffected by Rem~1--265~, indicating that both the BBD and ABD mechanisms require Rem~DCT~ ([Fig. 5D](#f0005){ref-type="fig"}). Rem~1--285~ inhibited both α~1C~/β~2a~ and α~1C~/β~2aTM~ channels with a pattern indicating that both the BBD and ABD pathways were largely intact ([Fig. 5D](#f0005){ref-type="fig"}). By contrast, Rem~1--275~ significantly inhibited α~1C~/β~2a~ but not α~1C~/β~2aTM~ channels ([Fig. 5D](#f0005){ref-type="fig"}), indicating a selective loss of the ABD mode of inhibition. These data show that both the BBD and ABD modes of inhibition require Rem~DCT~ but not in an identical manner.

Rem C-terminus is not sufficient to inhibit Ca~V~1.2 {#s0002-0005}
----------------------------------------------------

Could the interaction between Rem C-terminus and α~1C~ be sufficient to inhibit Ca~V~1.2? We explored this question by assessing the impact of a construct containing the last 75 amino acids of Rem (CFP-Rem~224--297~) on *I*~Ca,L~ from HEK293 cells expressing either wt (α~1C~/β~2a~) or mutant (α~1C~/β~2aTM~) Ca~V~1.2 channels ([Fig. 6](#f0006){ref-type="fig"}). A similar extended C-terminus construct derived from Gem was previously reported to be sufficient to inhibit recombinant Ca~V~2.1 channels.[@cit0044] Surprisingly, CFP-Rem~224--297~ had no effect on either α~1C~/β~2a~ or α~1C~/β~2aTM~ channels ([Fig. 6, A and B](#f0006){ref-type="fig"}), indicating Rem C-terminus is necessary but not sufficient for either BBD or ABD Ca~V~1.2 inhibition. This result implied an additional structural component in Rem is required for the observed ABD inhibition of Ca~V~1.2. Figure 6.Rem C-terminus is not sufficient for Ca~V~1.2 inhibition. (A) *J*~peak~─*V* relationships for α~1C~ + β~2a~ (▪, *n* = 4) and α~1C~ + β~2a~ + Rem~224--297~ (*n* = 8) channels. (B) *J*~peak~─*V* relationships for α~1C~ + β~2aTM~ (▪, *n* = 9) and α~1C~ + β~2aTM~ + Rem~224--297~ (□, *n* = 6) channels.

Rem G-domain is required for ABD Ca~V~1.2 inhibition {#s0002-0006}
----------------------------------------------------

We used a chimeric method to probe which additional Rem structural component(s) is required for BBD Ca~V~1.2 inhibition. The approach exploited the functional difference between Rem and Gem with regards to the prevalence of the 2 distinct modes of Ca~V~1.2 inhibition: whereas Rem diminishes *I*~Ca,L~ using both BBD and ABD mechanisms, Gem utilizes only the BBD pathway ([Fig. 1](#f0001){ref-type="fig"}). The inability of Gem to reconstitute ABD Ca~V~1.2 inhibition could be due to a failure to bind α~1C~-NT. Alternatively, Gem could potentially bind α~1C~-NT well but lack the additional component required to transduce the functional effect. FRET experiments in cells co-expressing CFP-Gem and YFP-α~1C~NT indicated no interaction between the 2 proteins ([Fig. 7A](#f0007){ref-type="fig"}). Could simply donating the capacity to bind α~1C~-NT to Gem be sufficient to reconstitute ABD Ca~V~1.2 block? To address this we examined the functional properties of a chimeric protein, Gem-r, in which the C-terminus of Gem was replaced with the corresponding region from Rem. Cells co-expressing YFP-α~1C~NT and CFP-Gem-r displayed robust FRET indicating successful transplantation of the capacity to directly bind α~1C~ ([Fig. 7A](#f0007){ref-type="fig"}). Functionally, CFP-Gem-r potently inhibits wt α~1C~/β~2a~ but has no effect on *I*~Ca,L~ recorded from mutant α~1C~/β~2aTM~ channels ([Fig. 7B](#f0007){ref-type="fig"}), indicating this chimera displays only BBD Ca~V~1.2 inhibition. Hence, simply targeting Gem to α~1C~-NT is not sufficient to reconstitute ABD inhibition of Ca~V~1.2. The results further suggested that additional component(s) present in Rem N-terminus and/or G-domain but lacking in Gem were necessary for ABD inhibition of Ca~V~1.2. Figure 7.Chimeric Rem/Gem analyses of determinants required for α~1C~-binding-dependent Ca~V~1.2 inhibition. (A) FRET detection of interactions between YFP-α~1C~NT and CFP-tagged Rem/Gem constructs. \**P* \< 0.05 compared with CFP-FRB using one-way ANOVA and Bonferroni tests. Data are means ± SEM. (B) *Left, J*~peak~─*V* relationships for α~1C~ + β~2a~ (▪, *n* = 6) and α~1C~ + β~2a~ + Gem-r (О, *n* = 4) channels. Data for α~1C~ + β~2a~ + Rem is reproduced for comparison (red line). *Right, J*~peak~─*V* relationships for α~1C~ + β~2aTM~ (▪, *n* = 9) and α~1C~ + β~2aTM~ + Gem-r (О, *n* = 8) channels. Data for α~1C~ + β~2aTM~ + Rem is reproduced for comparison (red line). (C) *Left, J*~peak~─*V* relationships for α~1C~ + β~2a~ (▪, *n* = 6) (data are same as in (B)) and α~1C~ + β~2a~ + r-Gem-r (▿, *n* = 7) channels. Data for α~1C~ + β~2a~ + Rem is reproduced for comparison (red line). *Right, J*~peak~─*V* relationships for α~1C~ + β~2aTM~ (▪, *n* = 9) and α~1C~ + β~2aTM~ + r-Gem-r (▿, *n* = 10) channels. Data for α~1C~ + β~2aTM~ + Rem is reproduced for comparison (red line). (D) *Left, J*~peak~─*V* relationships for α~1C~ + β~2a~ (▪, *n* = 6) (data are same as in (B)) and α~1C~ + β~2a~ + g-Rem (◊, *n* = 9) channels. Data for α~1C~ + β~2a~ + Rem is reproduced for comparison (red line). *Right, J*~peak~─*V* relationships for α~1C~ + β~2aTM~ (▪, *n* = 9) (data are same as in (C)) and α~1C~ + β~2aTM~ + g-Rem (◊, *n* = 8) channels. Data for α~1C~ + β~2aTM~ + Rem is reproduced for comparison (red line). Data are means ± SEM.

We generated 2 additional chimeras to test this assumption: r-Gem-r contains the N- and C-terminus extensions of Rem appended to Gem G-domain; and g-Rem which consists of Gem N-terminus attached to Rem G-domain and C-terminus. Both r-Gem-r and g-Rem retained the capacity to potently inhibit wt α~1C~/β~2a~ channels ([Fig. 7, C and D](#f0007){ref-type="fig"}). By contrast, the 2 chimeras showed a sharp dichotomy in their impact on mutant α~1C~/β~2aTM~ channels---r-Gem-r was without effect while g-Rem inhibited these channels to the same extent as wt Rem. Taken together, the results indicate that the ABD mode of Ca~V~1.2 inhibition minimally requires both the Rem~DCT~ and G-domain.

Discussion {#s0003}
==========

This study provides new insights into molecular determinants underlying Rem-mediated inhibition of Ca~V~1.2 channels. The data demonstrate that Rem~DCT~ binds α~1C~NT to initiate ABD Rem inhibition of Ca~V~1.2 channels. However, Rem C-terminus is not by itself sufficient to reconstitute ABD inhibition. Chimeric Rem/Gem analyses indicated that Rem (but not Gem) G-domain is also necessary for the ABD mechanism of Ca~V~1.2 inhibition.

The finding that Rem~DCT~ and G-domain are the essential motifs required for ABD inhibition of Ca~V~1.2 was unexpected for 2 main reasons. First, previous work has established that these same 2 regions also underlie BBD Rem inhibition of Ca~V~1.2.[@cit0026] To activate BBD inhibition, Rem~DCT~ binds the plasma membrane while the G-domain interacts with Ca~V~β in the channel complex. This configuration essentially uses Rem to cross-link Ca~V~β and by association, the intracellular α~1C~ I-II loop, to the plasma membrane ([Fig. 8](#f0008){ref-type="fig"}). This is hypothesized to induce a conformational change that effectively closes the channel pore. We previously exploited these insights into the BBD inhibition mechanism to develop a general approach─ termed channel inactivation induced by membrane-tethering an associated protein (ChIMP)---for generating novel genetically-encoded Ca~V~1/Ca~V~2 channel blockers.[@cit0027] For the ABD inhibition pathway, this study shows that Rem~DCT~ and G-domain are also utilized, but do so by interacting with different binding partners. In this case, Rem~DCT~ interacts with α~1C~NT. Precisely how the Rem G-domain participates in ABD inhibition of Ca~V~1.2 is not clear. We can deduce it plays an active role in the process because the homologous Gem G-domain cannot substitute for its function. The most likely scenario is that Rem G-domain selectively binds to another site within the cell, effectively cross-linking α~1C~NT to an intracellular anchor to initiate ABD Ca~V~1.2 inhibition ([Fig. 8](#f0008){ref-type="fig"}). Candidate regions for the putative Rem G-domain interaction site include somewhere on the α~1C~ subunit itself or the cytoskeleton. RGK proteins are known to interact with and regulate the cytoskeleton.[@cit0015] Identification of the presumed interaction site for Rem G-domain that is necessary for ABD Ca~V~1.2 inhibition is an important goal for future studies. Figure 8.Rem distal C-terminus and G-domain underlie both β-binding-dependent and α~1C~-binding-dependent Ca~V~1.2 inhibition. Cartoon showing Rem determinants and putative interaction sites responsible for β-binding-dependent and α~1C~-binding-dependent Ca~V~1.2 inhibition. Both types of inhibition rely on the Rem distal C-terminus (DCT) and G-domain (GD). For β-binding-dependent inhibition, Rem~DCT~ and GD bind the plasma membrane and Ca~V~β, respectively. For α~1C~-binding-dependent inhibition Rem~DCT~ binds α~1C~ N-terminus while GD interacts with a secondary site either on the channel itself or elsewhere.

The second reason why the finding that Rem~DCT~ and G-domain underlie ABD inhibition was surprising is that these 2 regions are the most highly conserved among RGK proteins. Nevertheless, Gem and Rem2 lack the capacity for ABD Ca~V~1.2 inhibition.[@cit0026] The distal C-termini of all 4 RGKs anchor the respective proteins to the plasma membrane.[@cit0046] Similarly, the G-domains of all RGKs bind Ca~V~β. The dual capability of all RGKs to bind the plasma membrane and Ca~V~βs provides a simple explanation for the rather unique feature that RGKs potently and non-selectively inhibit *all* Ca~V~1/Ca~V~2 channels, *i.e.* they accomplish this through the BBD pathway. The unique capability of Rem to bind α~1C~NT and initiate ABD Ca~V~1.2 inhibition reveals functional specialization among RGK C-termini and G-domains despite their high sequence homology.

Deepened understanding of how ABD inhibition arises could potentially be exploited to design novel genetically-encoded Ca~V~ channel blockers, in the same manner as we previously accomplished with the BBD mode of inhibition.[@cit0027] The particular advantage of leveraging the ABD pathway in this manner is the likelihood that this approach could yield *isoform-selective* genetically-encoded Ca~V~1/Ca~V~2 blockers. One potential merit of such blockers is that they can be genetically targeted to precise cell populations and sub-cellular localizations, affording a degree of spatial selectivity that is difficult to achieve with small molecules.[@cit0008] The prospect of engineering channel isoform selectivity into genetically encoded Ca~V~ channel blockers is intriguing and could potentially help address difficulties in developing selective small molecule blockers for specific Ca~V~ channel isoforms.[@cit0048]

What is the mechanism underlying ABD Ca~V~1.2 inhibition by Rem? We previously showed that Rem inhibits recombinant wt α~1C~/β~2a~ channels using at least 3 distinct mechanisms: (1) by reducing the number of channels at the cell surface; or by reducing the open probability (*P*~o~) of surface channels in 2 distinguishable ways─ (2) without an impact on voltage sensor movement (no effect on gating charge); (3) by partially immobilizing α~1C~ voltage sensors (reduced gating charge).[@cit0032] In mutant α~1C~/β~2aTM~ channels, 2 of the mechanistic signatures of Rem inhibition (decreased channel surface density and reduced *P*~o~ without an impact on voltage sensors) but not the third (reduced *P*~o~ by voltage sensor immobilization) were eliminated. These previous results suggest that ABD inhibition by Rem is due to a reduced *P*~o~ of surface channels mediated by a partial immobilization of α~1C~ voltage sensor(s). Given the continuity between α~1C~NT and the domain I (DI) S1-S4 voltage sensor it is tempting to speculate based on the "cross-linking model" we propose wherein Rem~DCT~ binds α~1C~NT while the G-domain binds to a second site, that Rem impedes movement of at least the α~1C~ DI voltage sensor. Voltage clamp fluorimetry experiments could be used to directly test how and which of the 4 α~1C~ voltage sensors are affected by Rem.[@cit0050]

Our findings add to a growing list of molecules regulating the gating of Ca~V~1 and Ca~V~2 channels by targeting the N-termini of pore-forming α~1~-subunits. These include reports that the α~1B~ N-terminus acts as a gated module that enables voltage-dependent G-protein βγ subunit inhibition of Ca~V~2.2 channels;[@cit0051] a role for α~1C~ N-terminus in protein kinase C modulation of Ca~V~1.2 channels;[@cit0052] that the N-termini of Ca~V~1.2 and Ca~V~1.3 channels contains a Ca^2+^-CaM binding site (termed NSCaTE for N-terminal spatial Ca^2+^ transforming element) that controls local vs. global spatial Ca^2+^ selectivity for CaM regulation of Ca~V~ channels;[@cit0054] and that deleting segments of α~1C~ N-terminus increases *I*~Ca,L~ by enhancing channel *P*~o~.[@cit0052]

Some aspects of our findings contrast with previous reports. While we found that Rem~DCT~ is necessary for Ca~V~1.2 inhibition, a Rem~224--297~ peptide that contained this whole region was not sufficient to block *I*~Ca,L~. This result is in agreement with previous observations that a peptide comprising the Rem distal C-terminus alone (Rem~266--297~) did not inhibit Ca~V~1.2 channels reconstituted in tsA201 cells,[@cit0029] and that Rem2 C-terminus had no impact on endogenous Ca~V~2.2 channels in SCG neurons.[@cit0030] By contrast, it was previously reported that Gem~223--296~ (which lacks the Gem G-domain) was sufficient to bind auxiliary Ca~V~β and strongly inhibit recombinant Ca~V~2.1 channels reconstituted in *Xenopus* oocytes.[@cit0044] Further, a different study showed that a 12 amino acid peptide derived from Gem C-terminus is also sufficient to inhibit Ca~V~2.1 channels in excised patches from *Xenopus* oocytes.[@cit0057] These seemingly conflicting results could be due to differences in experimental techniques, cell systems, or simply the result of an emerging pattern of distinct mechanistic differences among RGK proteins with regard to the Ca~V~ channels inhibition. However, we found that CFP-Gem~223--296~ did not bind Ca~V~β or inhibit either Ca~V~1.2 or Ca~V~2.1 channels reconstituted in HEK293 cells (Fig. S3).

Recently, Beqollari et al. (2014) found that while both Rad and Rem overexpressed in adult mice flexor digitorum brevis fibers potently inhibited endogenous Ca~V~1.1 currents, only Rad also reduced Ca~V~1.1 Vage sensor movement.[@cit0058] This is in contrast to cultured skeletal myotubes where Rem inhibited endogenous Ca~V~1.1 current concomitantly with a reduction in gating charge.[@cit0059] Chimeric Rad/Rem analyses indicated that the N-terminus of Rad was necessary for the reduced Ca~V~1.1 Vage-sensor movement in adult skeletal muscle fibers. Overall, taken together with these and other previous reports, our results add to a growing awareness that RGK inhibition of Ca~V~ channels is underlain by a rich variety of determinants and mechanisms that are specific for the RGK subtype, Ca~V~1/Ca~V~2 channel isoforms, and the cell context.[@cit0015]

Materials and methods {#s0004}
=====================

Molecular biology {#s0004-0001}
-----------------

To generate cyan fluorescent protein (CFP)-tagged RGK constructs \[mouse Rem (NM_009047); human Gem (NM_181702)\] we first cloned CFP into pcDNA4.1 (Invitrogen) using *KpnI* and *BamHI* sites. Subsequently, Rem and Gem cDNA were amplified using polymerase chain reaction (PCR) and cloned downstream of CFP using *BamHI* and *EcoRI* sites. To generate yellow fluorescent protein (YFP)-tagged Ca~V~β~2a~, we PCR amplified and cloned YFP into pAd CMV vector using *BamHI* and *XbaI* sites. Ca~V~β~2a~ was amplified by PCR and cloned upstream of YFP using *NheI* and *BamHI* sites. To generate YFP-tagged Ca~V~β~3~ we first cloned YFP into pcDNA3 using *KpnI* and *BamHI* sites. Subsequently, Ca~V~β~3~ was amplified downstream of YFP using *BamHI* and *Xba* sites. Point mutations in Ca~V~β were generated using QuikChange Site-Directed Mutagenesis Kit (Stratagene). PCR amplification and cloning was used to generate truncated Rem~275~ and Rem~285~ using *BamHI* and *EcoRI* sites. Chimeric RGK proteins were generated using overlap-extension PCR amplification and cloned into pcDNA4.1 (Invitrogen). All constructs were verified by sequencing.

Cell culture and transfection {#s0004-0002}
-----------------------------

HEK293 cells were maintained in DMEM supplemented with 10% FBS and 100 μg ml^−1^ penicillin-streptomycin. For electrophysiology experiments, HEK293 cells cultured in 35-mm tissue culture dishes were transiently transfected with α~1C~ (4 μg), β~2a~ (3 μg), T-antigen (2 μg) and the appropriate Rem, Gem or chimeric RGK construct (3 μg) using the calcium phosphate precipitation method. Cells were washed with PBS 4--6 h after transfection and maintained in supplemented DMEM. For confocal microscopy and FRET imaging experiments, transfected HEK293 cells were replated onto 35-mm fibronectin-coated No. 0 glass bottom culture dishes (MatTek). For electrophysiology experiments, cells were replated onto fibronectin-coated glass coverslips 24--48 h after transfection.

Generation of adenoviruses {#s0004-0003}
--------------------------

Rem-IRES-mCherry adenoviral vectors were generated using the Adeno-X CMV vector kit (Clontech). CFP-tagged adenoviral vectors were generated using the AdEasy XL Adenoviral Vector System (Agilent Technologies) as previously described.[@cit0031] The cDNA sequence comprising α~1C~NT (residues 1--153) and II-III intracellular loop (residues 800--942) were amplified using PCR and spliced in-frame downstream of CFP using overlap extension PCR. The whole cDNA cassette comprising either CFP-α~1C~NT or CFP-α~1C~ II-III loop was cloned into pShuttle for construction of adenoviral vectors using the AdEasy system.

Adult rat ventricular myocyte culture and infection {#s0004-0004}
---------------------------------------------------

Primary cultures of adult rat heart ventricular myocytes were prepared as previously described,[@cit0060] and in accordance with the guidelines of the Columbia University Animal Care and Use Committee. Briefly, male Sprague-Dawley rats (Harlan) were euthanized with an overdose of halothane. Hearts were excised and ventricular myocytes isolated by enzymatic digestion with 1.7 mg Liberase-TM enzyme mix (Roche) using a Langendorff perfusion apparatus. Myocytes were cultured on laminin-coated glass coverslips (for electrophysiology experiments) or MatTek dishes (for confocal imaging experiments) in Medium 199 (Life Technologies) supplemented with (in mM): 5 carnitine, 5 creatine, 5 taurine, 0.5% penicillin-streptomycin-glutamine (Life Technologies), and 5% (vol/vol) FBS (Life Technologies). Cells were infected with 10--20 μL of viral stock in a final volume of 1--2 mL.

Electrophysiology {#s0004-0005}
-----------------

Whole-cell recordings on HEK293 cells were conducted 48--72 h after transfection at room temperature using an EPC-8 or EPC-10 patch clamp amplifier controlled by PULSE software (HEKA). Micropipettes were fashioned from 1.5 mm thin-walled glass with filament (World Precision Instruments). Series resistance was typically 1.7--2.5 MΩ. Internal solution contained (in mM): 135 cesium methanesulphonate (MeSO~3~), 5 cesium chloride, 5 EGTA, 1 MgCl~2~, 10 HEPES and 4 MgATP added fresh (pH 7.3). External solution contained (in mM): 140 tetraethylammonium-MeSO~3~, 5 BaCl~2~ and 10 HEPES (pH 7.3). Whole-cell *I-V* curves were generated from a family of step depolarizations (−50 to +70 mV from a holding potential of −90 mV). Currents were sampled at 25 kHz and filtered at 10 kHz. Traces were acquired at a repetition interval of 6 s. Leak and capacitive currents were subtracted using a P/8 protocol.

Whole-cell recordings of cultured rat ventricular myocytes were conducted at room temperature. Patch pipettes used typically had 1--2 MΩ series resistance when filled with internal solution containing (in mM): 150 cesium-methanesulfonate, 10 EGTA, 5 CsCl, 1MgCl~2~, 10 HEPES and 4 MgATP added fresh (pH 7.3). Cells were perfused with normal Tyrode external solution during formation of gigaohm seal. Tyrode external solution contained (in mM): 138 NaCl, 4KCl, 2 CaCl~2~, 1 MgCl2, 0.33 NaH~2~PO~4~, 10 HEPES (pH 7.4). After successful break-in to the whole-cell configuration the perfusing medium was switched to an external recording solution containing (in mM): 155 N-methy-D-glucamine-aspartate, 10 4-aminopyridine, 1 MgCl~2~, 5 BaCl~2~, 10 HEPES (pH 7.4). Currents were sampled at 50 KHz and filtered at 5 KHz and leak and capacitive currents were subtracted using a P/8 protocol.

Immunoprecipitation and Western blotting {#s0004-0006}
----------------------------------------

Confluent cultures of HEK293 cells plated in 60-mm tissue culture dishes were harvested 48 h after transfection. Cells were washed in PBS and resuspended in 0.5 mL cold lysis buffer (50 mmol/L Tris-HCl, 150 mmol/L NaCl, 1% NP-40) containing protease inhibitor cocktail for 30 minutes. Cell lysates were centrifuged at 10,000 × g for 15 minutes at 4°C, and the supernatant precleared by incubation with 30 μL protein G beads slurry for 1 h. The mixture was centrifuged and the resulting supernatant incubated with 4 μg anti-Rem (SC58472, Santa Cruz) antibody and 30 μL protein G slurry for 1 h on a rotator. The mixture was again centrifuged, and the pellet washed 4 times with lysis buffer. 50 μL Laemmli sample buffer was added to the bead pellet and the mixture vortexed and heated (95°C for 10 minutes). The sample was centrifuged and the supernatant loaded onto a gel for subsequent SDS-PAGE and Western blot analyses. For immunoblots, primary antibodies to GFP (Invitrogen, A6455) were detected by horse-radish peroxidase-conjugated secondary antibodies (goat-anti rabbit obtained from Thermo Scientific, 32260) and enhanced chemiluminescence (Thermo Scientific, 34080).

Confocal imaging {#s0004-0007}
----------------

Static images of HEK 293 and cultured rat ventricular myocytes cells expressing CFP- and YFP-tagged proteins were imaged using a Leica TCS SP2 AOBS MP Confocal microscope with a 40 × oil objective (HCX PL APO 1.25--.75 NA). 458/514 nm argon laser line was used for excitation of fluorescent protein-tagged constructs.

FRET imaging {#s0004-0008}
------------

Three-cube FRET assay with CFP- (donor) and YFP-tagged (acceptor) molecules was used to probe specific protein-protein interactions in live cells as previously described.[@cit0039] Fluorescence images were acquired using a 40x oil objective (NA 1.3) on a Nikon Eclipse Ti-U inverted microscope fitted with an electron-multiplying CCD camera (QuantEM:512SC, Photometrics). Excitation wavelengths of 440 nm (CFP and FRET cubes) and 500 nm (YFP cube) were applied using a random access monochromator with a 75 W Xenon Arc lamp housing (PTI DeltaRam X, Photon Technology International). FRET efficiency was measured by acquiring 3 separate signals for each donor-acceptor pair condition: the donor channel (DD) which excites and detects donor emission, the acceptor channel (AA) which excites and detects acceptor emission, and the FRET channel (DA) which excites the donor and detects acceptor emission. The filter cubes used were (dichroic, emission): DD (455DCLP, D480/30M); AA (525DRLP, 530EFLP); DA (455DRLP, 535DF25). Cross-talk parameters were determined by imaging cells expressing either donor (CFP) or acceptor (YFP) fluorescent proteins alone. To avoid outlying data points only donor/acceptor ratios from 0.1 to 6 and signal/noise ratios with a minimum of 2 were used for FRET efficiency calculations. FRET efficiency and relative donor and acceptor concentrations were calculated as described.[@cit0040]

Data and statistical analyses {#s0004-0009}
-----------------------------

Data were analyzed off-line using PulseFit (HEKA), Microsoft Excel and Origin software. Data were plotted and statistical analyses were performed in Origin using built-in functions. Statistically significant differences between means (*P* \< 0.05) were determined using one-way ANOVA followed by Bonferroni post hoc analyses for comparisons involving more than 2 groups. Data are represented as means ± SEM.

Supplementary Material
======================

###### KCHL_S\_1180489.pdf

Disclosure of potential conflicts of interest {#s0005}
=============================================

No potential conflicts of interest were disclosed.

Acknowledgments
===============

We thank Ming Chen for technical assistance and members of the Colecraft lab for helpful discussions.

Funding
=======

This research was supported by a grant from the National Institutes of Health (R01 GM107585 to HMC); an AHA predoctoral fellowship (13PRE13970018 to AAP), a UNCF-Merck graduate dissertation fellowship (CU11-2479 to AAP), and an American Heart Association Established Investigator Award (HMC).

[^1]: Color versions of one or more of the figures in the article can be found online at [www.tandfonline.com/kchl](http://www.tandfonline.com/kchl).

[^2]: Supplemental data for this article can be accessed on the [publisher\'s website](http://dx.doi.org/10.1080/19336950.2016.1180489).
